Compile Data Set for Download or QSAR
maximum 50k data
Found 134 Enz. Inhib. hit(s) with all data for entry = 797
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291270((R)-tert-butyl 3-(4-amino-3-iodo-1H-pyrazolo[3,4-d...)
Affinity DataIC50:  0.415nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291281(US9580432, Example 12)
Affinity DataIC50:  0.433nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291310(US9580432, Example 41)
Affinity DataIC50:  0.442nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291272((R)-4-amino-1-(1-(tert-butyloxycarbonyl)pyrrolidin...)
Affinity DataIC50:  0.443nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291276(US9580432, Example 7)
Affinity DataIC50:  0.457nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291271((R)-4-amino-1-(1-(tert-butyloxycarbonyl)piperidin-...)
Affinity DataIC50:  0.464nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291298(US9580432, Example 29)
Affinity DataIC50:  0.485nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291312(US9580432, Example 43)
Affinity DataIC50:  0.546nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291297(US9580432, Example 28)
Affinity DataIC50:  0.559nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291299(US9580432, Example 30)
Affinity DataIC50:  0.566nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291293(US9580432, Example 24 | US9580432, Example 48)
Affinity DataIC50:  0.591nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291301(US9580432, Example 32)
Affinity DataIC50:  0.634nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291288(US9580432, Example 19)
Affinity DataIC50:  0.690nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291285(US9580432, Example 16)
Affinity DataIC50:  0.733nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291275(US9580432, Example 6)
Affinity DataIC50:  0.738nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291311(US9580432, Example 42)
Affinity DataIC50:  0.771nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291290(US9580432, Example 21)
Affinity DataIC50:  0.777nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291306(US9580432, Example 37)
Affinity DataIC50:  0.786nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291284(US9580432, Example 15)
Affinity DataIC50:  0.786nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291287(US9580432, Example 18)
Affinity DataIC50:  0.788nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291303(US9580432, Example 34)
Affinity DataIC50:  0.790nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291304(US9580432, Example 35)
Affinity DataIC50:  0.792nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291324(US9580432, Example 55)
Affinity DataIC50:  0.799nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291289(US9580432, Example 20)
Affinity DataIC50:  0.801nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291286(US9580432, Example 17)
Affinity DataIC50:  0.811nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291282(US10280174, Compound A | US9580432, Example 13)
Affinity DataIC50:  0.813nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291293(US9580432, Example 24 | US9580432, Example 48)
Affinity DataIC50:  0.836nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291305(US9580432, Example 36)
Affinity DataIC50:  0.867nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291313(US9580432, Example 44)
Affinity DataIC50:  0.877nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291302(US9580432, Example 33)
Affinity DataIC50:  0.887nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291307(US9580432, Example 38)
Affinity DataIC50:  0.888nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291273(5-cyanobenzo[d]oxazol-2-amine | US9580432, Example...)
Affinity DataIC50:  0.888nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291308(US9580432, Example 39)
Affinity DataIC50:  1.12nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291294(US9580432, Example 25)
Affinity DataIC50:  1.17nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291321(US9580432, Example 52)
Affinity DataIC50:  1.20nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291314(US9580432, Example 45)
Affinity DataIC50:  1.25nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291274(US9580432, Example 5)
Affinity DataIC50:  1.25nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291277(US9580432, Example 8)
Affinity DataIC50:  1.27nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM50357312(IBRUTINIB | PCI-32765 | US10124003, Ref. Ex. Compo...)
Affinity DataIC50:  1.30nMpH: 7.5 T: 2°CAssay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against EGFR kinase activity in vitro, ...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291325(US9580432, Example 56)
Affinity DataIC50:  1.34nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291278(US9580432, Example 9)
Affinity DataIC50:  1.37nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291319(US9580432, Example 50)
Affinity DataIC50:  1.41nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291296(US9580432, Example 27)
Affinity DataIC50:  1.43nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291323(US9580432, Example 54)
Affinity DataIC50:  1.44nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291320(US9580432, Example 51)
Affinity DataIC50:  1.48nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291326(US9580432, Example 57)
Affinity DataIC50:  1.51nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291328(US9580432, Example 59)
Affinity DataIC50:  1.51nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291318(US9580432, Example 49)
Affinity DataIC50:  1.53nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291292(US9580432, Example 23)
Affinity DataIC50:  1.58nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM291300(US9580432, Example 31)
Affinity DataIC50:  1.67nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 134 total ) | Next | Last >>
Jump to: